Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients
Launched by HATICE KÜBRA AŞIK · Dec 7, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
1. Full name of the study: Nuclear Magnetic Resonance Based Metabolomic Profiling in Fibromyalgia Patients
2. Aim and importance of the study (primary aim, secondary aims, if any):
Determination and quantitation of metabolites and enzyme activities by NMR in fibromyalgia patients, changes in citrate, isocitrate, alpha ketoglutarate, alpha ketoglutarate, succinyl CoA, fumarate, malate, glutamate, G-6 PD, phosphogluconate, glyceraldehyde 3 P and oxaloacetate values, especially in energy metabolism in these patients and evaluation of their clinical usefulness will be investigated.
3. Expec...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients aged 18-65 years Patients with clinical complaints of fibromyalgia
- Exclusion Criteria:
- • Viral or bacterial infections, Diabetes mellitus, Hypertension, Chronic renal failure, Hypo-hyperthyroidism) Patients taking antidepressants or medication, Smokers and alcohol users, Patients with rheumatic arthritis and systemic lupus erythematosus were excluded.
- • -
About Hatice Kübra Aşık
Hatice Kübra Aşık is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient outcomes through rigorous study designs and ethical oversight. With a focus on innovative therapeutic solutions, Ms. Aşık collaborates with healthcare professionals and research institutions to ensure the integrity and reliability of clinical trials. Her expertise in regulatory compliance and patient safety underscores her commitment to fostering an environment where groundbreaking discoveries can flourish, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported